(Total Views: 367)
Posted On: 04/18/2022 11:13:17 AM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Don Huffman has experience in merger and acquisition of biology and medical companies. CFO of 4 public companies. Three listed on NASDAQ and one OTC. Served on the board of SteadyMed Ltd. Which was purchased for 4.46 per share and a additional 2.63 a share with achievement milestone.
Possibly the best choice for shareholders.
Possibly the best choice for shareholders.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)